首页 > 最新文献

Journal of Clinical Pathology最新文献

英文 中文
Seasonal variation of serum potassium and related prescription pattern: an ecological time series. 血清钾的季节性变化及相关处方模式:生态时间序列。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-19 DOI: 10.1136/jcp-2023-208759
Rasiah Thayakaran, Richard Hotham, Krishna M Gokhale, Nicola J Adderley, Joht Singh Chandan, Krishnarajah Nirantharakumar

Aims To assess if ambient temperature-related effects on serum potassium levels impact clinical decision-making. Methods This study is an ecological time series consisiting of 1 218 453 adult patients with at least one ACE inhibitor (ACEI) prescription who participate in a large UK primary care dataset.Descriptive statistics and a quasi-Poisson regression model using time series data at regular time intervals (monthly) were undertaken to examine the association between potassium measurements and ACEI/potassium supplement prescriptions. RESULTS: It is noted that correlating with lower ambient temperature, serum potassium values follow a seasonal pattern; peaks in winter months and troughs in summer. During summer months, there are clear annual spikes in the number of potassium prescriptions suggesting a change in prescribing practice during periods of potentially spurious hyperkalaemia. The converse pattern is seen in the ACEI prescription proportion which spikes annually during the winter period with lower average ambient temperatures. Our time series modelling demonstrated that each one unit increase in potassium is associated with a 33% increased rate of ACEI prescriptions (risk ratio, RR 1.33; 95% CI 1.12 to 1.59) and 63% decreased rate of potassium supplements (RR 0.37; 95% CI 0.32 to 0.43). CONCLUSIONS: Our findings highlight the seasonal pattern in serum potassium and we observe a corresponding alteration in prescribing practice for potassium sensitive medications. These findings demonstrate the importance of educating clinicians on the presence of seasonal potassium variability in addition to standard measurement error, and its potential impact on their prescribing activity.

目的 评估环境温度对血清钾水平的影响是否会影响临床决策。本研究是一项生态时间序列研究,包括 1 218 453 名成年患者,他们至少有一个 ACE 抑制剂(ACEI)处方,这些患者参与了英国的一个大型初级保健数据集。本研究使用时间序列数据,以固定的时间间隔(每月一次)进行描述性统计和准泊松回归模型,以研究钾测量值与 ACEI/钾补充剂处方之间的关联。结果:结果表明,与较低的环境温度相关,血清钾值呈现季节性模式:冬季达到峰值,夏季达到谷值。在夏季,钾处方的数量每年都会出现明显的高峰,这表明在可能出现假性高钾血症的时期,处方做法发生了变化。而 ACEI 处方比例则与之相反,在平均环境温度较低的冬季,ACEI 处方比例每年都会激增。我们的时间序列模型显示,钾每增加一个单位,血管紧张素转换酶抑制剂的处方率就会增加 33%(风险比,RR 1.33;95% CI 1.12 至 1.59),而钾补充剂的处方率则会降低 63%(RR 0.37;95% CI 0.32 至 0.43)。结论:我们的研究结果突显了血清钾的季节性变化规律,并观察到钾敏感药物处方的相应变化。这些研究结果表明,除了标准测量误差外,教育临床医生了解钾的季节性变化及其对处方活动的潜在影响也非常重要。
{"title":"Seasonal variation of serum potassium and related prescription pattern: an ecological time series.","authors":"Rasiah Thayakaran, Richard Hotham, Krishna M Gokhale, Nicola J Adderley, Joht Singh Chandan, Krishnarajah Nirantharakumar","doi":"10.1136/jcp-2023-208759","DOIUrl":"10.1136/jcp-2023-208759","url":null,"abstract":"<p><p><b>Aims</b> To assess if ambient temperature-related effects on serum potassium levels impact clinical decision-making. <b>Methods</b> This study is an ecological time series consisiting of 1 218 453 adult patients with at least one ACE inhibitor (ACEI) prescription who participate in a large UK primary care dataset.Descriptive statistics and a quasi-Poisson regression model using time series data at regular time intervals (monthly) were undertaken to examine the association between potassium measurements and ACEI/potassium supplement prescriptions. RESULTS: It is noted that correlating with lower ambient temperature, serum potassium values follow a seasonal pattern; peaks in winter months and troughs in summer. During summer months, there are clear annual spikes in the number of potassium prescriptions suggesting a change in prescribing practice during periods of potentially spurious hyperkalaemia. The converse pattern is seen in the ACEI prescription proportion which spikes annually during the winter period with lower average ambient temperatures. Our time series modelling demonstrated that each one unit increase in potassium is associated with a 33% increased rate of ACEI prescriptions (risk ratio, RR 1.33; 95% CI 1.12 to 1.59) and 63% decreased rate of potassium supplements (RR 0.37; 95% CI 0.32 to 0.43). CONCLUSIONS: Our findings highlight the seasonal pattern in serum potassium and we observe a corresponding alteration in prescribing practice for potassium sensitive medications. These findings demonstrate the importance of educating clinicians on the presence of seasonal potassium variability in addition to standard measurement error, and its potential impact on their prescribing activity.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9588463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ciliated foregut cysts involving the hepatopancreaticobiliary system: a clinicopathological evaluation with focus on atypical features. 累及肝胰胆系统的纤毛前肠囊肿:临床病理评估,重点关注非典型特征。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-19 DOI: 10.1136/jcp-2023-208947
Pooja Navale, Jonathan Glickman, Imad Nasser, Jinru Shia, Monika Vyas

Aims: Foregut cystic malformations are rare developmental abnormalities, which may involve the hepatopancreaticobiliary tract (HPBT). These cysts are composed of inner ciliated epithelium; subepithelial connective tissue layer; smooth muscle layer; and an outer fibrous layer. While radiopathologic findings are often diagnostic, atypical location and histologic features can pose a diagnostic challenge. We aimed to study ciliated foregut cysts (CFCs) in the HPBT, assess their clinicopathological features with a focus on atypical features.

Methods: We collected cases of CFCs involving the HPBT from three large academic medical centres. H&E-stained slides and immunohistochemical stains (where available) were reviewed for each case. Relevant demographic, clinical and pathological information was collected from the medical records.

Results: 21 cases were identified. The median age was 53 years (range, 3-78 years). 17 cysts were identified within the liver (segment 4 was the most common location, n=10) and 4 in the pancreas. Cysts were mostly identified incidentally (n=13), abdominal pain was a common symptom (n=5). Cyst size ranged from 0.7 to 17.0 cm (median, 2.5 cm). Radiological findings were available in 17 cases. Cilia were identified in all cases. 19 of 21 cases demonstrated the presence of a smooth muscle layer (thickness, <0.1 mm to 3.0 mm). Three cases showed gastric metaplasia, while one case revealed additional low-grade dysplasia, with features similar to intraductal papillary neoplasm of the bile duct.

Conclusions: We highlight clinicopathological features of CFCs in the HPBT. The histomorphology is usually straightforward; however, unusual location and atypical features can pose a diagnostic challenge.

目的:前肠囊肿畸形是一种罕见的发育异常,可能会累及肝胰胆管(HPBT)。这些囊肿由内层纤毛上皮、上皮下结缔组织层、平滑肌层和外层纤维层组成。虽然放射病理检查结果通常具有诊断意义,但不典型的位置和组织学特征会给诊断带来挑战。我们旨在研究 HPBT 中的纤毛前肠囊肿(CFCs),评估其临床病理特征,重点关注非典型特征:我们从三个大型学术医疗中心收集了涉及 HPBT 的 CFCs 病例。我们对每个病例的 H&E 染色切片和免疫组化染色(如有)进行了审查。从病历中收集了相关的人口统计学、临床和病理学信息。中位年龄为 53 岁(3-78 岁)。在肝脏中发现了17个囊肿(第4节段是最常见的位置,10个),在胰腺中发现了4个囊肿。囊肿大多是偶然发现的(13 例),腹痛是常见症状(5 例)。囊肿大小从0.7厘米到17.0厘米不等(中位数为2.5厘米)。17例患者有放射学检查结果。所有病例均能发现纤毛。21 个病例中有 19 个病例显示存在平滑肌层(厚度,结论:我们强调了 HPBT 中 CFC 的临床病理特征。组织形态学通常比较简单;但是,不寻常的位置和不典型的特征会给诊断带来挑战。
{"title":"Ciliated foregut cysts involving the hepatopancreaticobiliary system: a clinicopathological evaluation with focus on atypical features.","authors":"Pooja Navale, Jonathan Glickman, Imad Nasser, Jinru Shia, Monika Vyas","doi":"10.1136/jcp-2023-208947","DOIUrl":"10.1136/jcp-2023-208947","url":null,"abstract":"<p><strong>Aims: </strong>Foregut cystic malformations are rare developmental abnormalities, which may involve the hepatopancreaticobiliary tract (HPBT). These cysts are composed of inner ciliated epithelium; subepithelial connective tissue layer; smooth muscle layer; and an outer fibrous layer. While radiopathologic findings are often diagnostic, atypical location and histologic features can pose a diagnostic challenge. We aimed to study ciliated foregut cysts (CFCs) in the HPBT, assess their clinicopathological features with a focus on atypical features.</p><p><strong>Methods: </strong>We collected cases of CFCs involving the HPBT from three large academic medical centres. H&E-stained slides and immunohistochemical stains (where available) were reviewed for each case. Relevant demographic, clinical and pathological information was collected from the medical records.</p><p><strong>Results: </strong>21 cases were identified. The median age was 53 years (range, 3-78 years). 17 cysts were identified within the liver (segment 4 was the most common location, n=10) and 4 in the pancreas. Cysts were mostly identified incidentally (n=13), abdominal pain was a common symptom (n=5). Cyst size ranged from 0.7 to 17.0 cm (median, 2.5 cm). Radiological findings were available in 17 cases. Cilia were identified in all cases. 19 of 21 cases demonstrated the presence of a smooth muscle layer (thickness, <0.1 mm to 3.0 mm). Three cases showed gastric metaplasia, while one case revealed additional low-grade dysplasia, with features similar to intraductal papillary neoplasm of the bile duct.</p><p><strong>Conclusions: </strong>We highlight clinicopathological features of CFCs in the HPBT. The histomorphology is usually straightforward; however, unusual location and atypical features can pose a diagnostic challenge.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9759505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of antigen-presenting cells in gingival tissues in healthy and periodontitis patients. 健康牙龈组织和牙周炎患者牙龈组织中抗原递呈细胞的比较分析。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-19 DOI: 10.1136/jcp-2021-207975
Ana Pejcic, Zlatibor Andjelkovic, Dragan Marjanovic, Ivan Minic, Vladimir Matvijenko, Zoran Arsic, Radovan Jovanovic, Ljiljana Subaric

Aims: Microbial flora of dental plaque trigger innate and adaptive immune responses. The function of antigen-presenting cells (APCs) is to bridge the innate and adaptive immune systems. The human immune system contains three main types of APCs: dendritic cells (DC) (Langerhans cells (LCs) and interstitial DCs, IDCs), macrophages and B lymphocytes. In this study, the distribution and density of all APCs in healthy and inflamed human gingival tissue were comparatively analysed.

Methods: Research was conducted on gingival biopsy specimens obtained from 55 patients and classified in three groups: healthy gingiva (control group, n=10), moderate periodontal disease (PD) (n=21) and severe PD (n=24). For APCs' identification antibodies raised against CD1a (for LCs), S100 protein (for iDCs), CD68 (for macrophages) and CD20 (for B lymphocytes) were used.

Results: Increased density of IDCs, macrophages and B lymphocytes in lamina propria and reduced density of LCs in the gingival epithelium were found in patients with periodontitis. Simultaneously, it was noticed an increased concentration of macrophages and B cells in the gingival epithelium in patients with PD. No statistically significant difference in the distribution and density of APC was found among patients with moderate and advanced periodontitis.

Conclusions: It was hypothesised that in the periodontitis the role of antigen presentation was largely taken from LCs by the DCs, macrophages and B cells. These APCs are thought to have less protective and tolerogenic potential than LCs and this is a significant reason for alveolar bone destruction in periodontitis.

目的:牙菌斑中的微生物菌群可引发先天性和适应性免疫反应。抗原递呈细胞(APC)的功能是连接先天性免疫系统和适应性免疫系统。人体免疫系统包含三种主要类型的 APC:树突状细胞(DC)(朗格汉斯细胞(LC)和间质 DC,IDC)、巨噬细胞和 B 淋巴细胞。本研究比较分析了所有 APCs 在健康和发炎人体牙龈组织中的分布和密度:研究对象为 55 名患者的牙龈活检标本,分为三组:健康牙龈(对照组,10 人)、中度牙周病(21 人)和重度牙周病(24 人)。鉴定 APCs 时使用了 CD1a(LCs)、S100 蛋白(iDCs)、CD68(巨噬细胞)和 CD20(B 淋巴细胞)抗体:结果:发现牙周炎患者固有层中 IDCs、巨噬细胞和 B 淋巴细胞的密度增加,而牙龈上皮中 LCs 的密度降低。同时,还发现牙周炎患者的牙龈上皮中巨噬细胞和 B 细胞的浓度增加。中度和晚期牙周炎患者的 APC 分布和密度在统计学上没有明显差异:结论:据推测,在牙周炎中,抗原递呈的作用主要由 DC、巨噬细胞和 B 细胞从 LCs 中承担。这些 APC 被认为比 LCs 的保护性和耐受性更差,这是牙周炎牙槽骨破坏的一个重要原因。
{"title":"Comparative analysis of antigen-presenting cells in gingival tissues in healthy and periodontitis patients.","authors":"Ana Pejcic, Zlatibor Andjelkovic, Dragan Marjanovic, Ivan Minic, Vladimir Matvijenko, Zoran Arsic, Radovan Jovanovic, Ljiljana Subaric","doi":"10.1136/jcp-2021-207975","DOIUrl":"10.1136/jcp-2021-207975","url":null,"abstract":"<p><strong>Aims: </strong>Microbial flora of dental plaque trigger innate and adaptive immune responses. The function of antigen-presenting cells (APCs) is to bridge the innate and adaptive immune systems. The human immune system contains three main types of APCs: dendritic cells (DC) (Langerhans cells (LCs) and interstitial DCs, IDCs), macrophages and B lymphocytes. In this study, the distribution and density of all APCs in healthy and inflamed human gingival tissue were comparatively analysed.</p><p><strong>Methods: </strong>Research was conducted on gingival biopsy specimens obtained from 55 patients and classified in three groups: healthy gingiva (control group, n=10), moderate periodontal disease (PD) (n=21) and severe PD (n=24). For APCs' identification antibodies raised against CD<sub>1a</sub> (for LCs), S<sub>100</sub> protein (for iDCs), CD<sub>68</sub> (for macrophages) and CD<sub>20</sub> (for B lymphocytes) were used.</p><p><strong>Results: </strong>Increased density of IDCs, macrophages and B lymphocytes in lamina propria and reduced density of LCs in the gingival epithelium were found in patients with periodontitis. Simultaneously, it was noticed an increased concentration of macrophages and B cells in the gingival epithelium in patients with PD. No statistically significant difference in the distribution and density of APC was found among patients with moderate and advanced periodontitis.</p><p><strong>Conclusions: </strong>It was hypothesised that in the periodontitis the role of antigen presentation was largely taken from LCs by the DCs, macrophages and B cells. These APCs are thought to have less protective and tolerogenic potential than LCs and this is a significant reason for alveolar bone destruction in periodontitis.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9826474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraductal carcinoma of the prostate: conflicting recommendations confuse clinicians 前列腺导管内癌:相互矛盾的建议让临床医生无所适从
IF 3.4 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-18 DOI: 10.1136/jcp-2024-209690
Murali Varma, Daniel M Berney, Glen Kristiansen, Theodorus H van der Kwast
Intraductal carcinoma of the prostate (IDCP) generally represents a growth pattern of invasive aggressive acinar prostate cancer but may rarely represent a non-invasive putative precursor of prostate cancer.1 IDCP in needle biopsies may be encountered in isolation or in association with invasive prostate cancer. While there is consensus that pure IDCP in needle biopsies should not be graded, it is controversial whether IDCP associated with invasive cancer should be included in the Gleason score (GS). The International Society of Urological Pathology (ISUP) recommended incorporating the IDCP component into the GS, but the Genitourinary Pathology Society (GUPS) proposed grading only the invasive component with comments on the presence of associated IDCP and its adverse prognostic significance.2 3 The impact of these conflicting recommendations is greatest in needle biopsies with invasive GS 3+3 and extensive IDCP because such cases would be graded as at least GS 4+3 (grade group 3) based on the ISUP guidelines but GS 3+3 (grade group 1) as per the GUPS recommendation. In this issue, McDonald et al describe such a case where the …
前列腺导管内癌(IDCP)通常代表侵袭性侵袭性尖锐湿疣前列腺癌的生长模式,但在极少数情况下也可能代表前列腺癌的非侵袭性假定前兆1。1 针式活组织检查中的 IDCP 可能是单独存在的,也可能与浸润性前列腺癌同时存在。虽然人们一致认为针式活组织检查中的纯 IDCP 不应分级,但与浸润性前列腺癌相关的 IDCP 是否应纳入格里森评分(GS)却存在争议。国际泌尿病理学会(ISUP)建议将 IDCP 部分纳入 GS,但泌尿生殖病理学会(GUPS)建议仅对浸润性部分进行分级,并对是否存在相关 IDCP 及其不良预后意义进行评论。3 这些相互矛盾的建议对具有侵袭性 GS 3+3 和广泛 IDCP 的针刺活检的影响最大,因为根据 ISUP 的指南,此类病例至少会被分级为 GS 4+3(3 级组),但根据 GUPS 的建议,则会被分级为 GS 3+3(1 级组)。在本期中,McDonald 等人描述了这样一个病例,其...
{"title":"Intraductal carcinoma of the prostate: conflicting recommendations confuse clinicians","authors":"Murali Varma, Daniel M Berney, Glen Kristiansen, Theodorus H van der Kwast","doi":"10.1136/jcp-2024-209690","DOIUrl":"https://doi.org/10.1136/jcp-2024-209690","url":null,"abstract":"Intraductal carcinoma of the prostate (IDCP) generally represents a growth pattern of invasive aggressive acinar prostate cancer but may rarely represent a non-invasive putative precursor of prostate cancer.1 IDCP in needle biopsies may be encountered in isolation or in association with invasive prostate cancer. While there is consensus that pure IDCP in needle biopsies should not be graded, it is controversial whether IDCP associated with invasive cancer should be included in the Gleason score (GS). The International Society of Urological Pathology (ISUP) recommended incorporating the IDCP component into the GS, but the Genitourinary Pathology Society (GUPS) proposed grading only the invasive component with comments on the presence of associated IDCP and its adverse prognostic significance.2 3 The impact of these conflicting recommendations is greatest in needle biopsies with invasive GS 3+3 and extensive IDCP because such cases would be graded as at least GS 4+3 (grade group 3) based on the ISUP guidelines but GS 3+3 (grade group 1) as per the GUPS recommendation. In this issue, McDonald et al describe such a case where the …","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142268741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular mimicry and mosaic vessels in parathyroid tumours: a new diagnostic approach? 甲状旁腺肿瘤的血管模拟和镶嵌血管:一种新的诊断方法?
IF 3.4 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-17 DOI: 10.1136/jcp-2024-209703
Monica Falleni, Matteo Dal Lago, Delfina Tosi, Giorgio Ghilardi, Loredana De Pasquale, Alberto M Saibene, Giovanni Felisati, Mario Cozzolino, Umberto Gianelli
Aims Evaluation of ‘alternative’ vascularisation in human cancer is considered an important prognostic parameter; the 2022 WHO classification of parathyroid tumours despite progresses in clinical triaging of patients strongly emphasises new histopathological parameters to properly stratify these lesions. ‘Alternative’ and ‘classic’ vessels were here investigated for the first time in parathyroid tumours for their possible histopathological and clinical relevance during progression. Methods Using a double CD31/PAS staining, microvessel density (MVD, ‘classic’ CD31+ vessels), mosaic vessel density (MoVD, ‘alternative’ CD31+/−vessels) and vessel mimicry density (VMD, ‘alternative’ CD31−/PAS+ vessels) were evaluated in 4 normal parathyroid glands (N), 50 Adenomas (A), 35 Atypical Tumours (AT) and 10 Carcinomas (K). Results Compared with N, MVD significantly increased in A (p=0.012) and decreased in K (p=0.013) with vessel counts lower than in AT and A (p<0.001). MoVs and VMs, absent in normal tissue, were documented in non-benign parathyroid lesions (AT, K) (p<0.001), with MoVs and VMs most represented in AT and K, respectively (p<0.001), in peripheral growing areas. Vessel distribution was correlated to neoplastic progression (r=−0.541 MVD; r=+0.760 MoVD, r=+0.733 VMD), with MVD decrease in AT and K inversely related to MoVD and VMD increase (r=−0.503 and r=−0.456). Conclusions ‘Alternative’ vessel identification in parathyroid tumours is crucial because it: (1) explains the paradox of non-angiogenic tumours, consisting in a new bloody non-endothelial vessel network and (2) helps pathologists to unmask worrisome lesions. Furthermore, detection of alternative vascular systems in human tumours might explain the limited success of antiangiogenic therapies and encourage new oncological studies. All data relevant to the study are included in the article or uploaded as supplementary information.
目的 评估人类癌症中的 "另类 "血管被认为是一个重要的预后参数;尽管在临床分流病人方面取得了进展,但2022年世界卫生组织对甲状旁腺肿瘤的分类仍然非常强调新的组织病理学参数,以便对这些病变进行适当的分层。本文首次研究了甲状旁腺肿瘤中的 "替代 "血管和 "经典 "血管,以了解它们在肿瘤进展过程中可能存在的组织病理学和临床意义。方法 采用双重 CD31/PAS 染色法,对 4 个正常甲状旁腺(N)、50 个腺瘤(A)、35 个非典型肿瘤(AT)和 10 个癌(K)的微血管密度(MVD,"经典 "CD31+ 血管)、镶嵌血管密度(MoVD,"另类 "CD31+/-血管)和血管模拟密度(VMD,"另类 "CD31-/PAS+ 血管)进行评估。结果 与 N 相比,A 的 MVD 明显增加(p=0.012),K 的 MVD 明显减少(p=0.013),血管数量低于 AT 和 A(p<0.001)。在非良性甲状旁腺病变(AT、K)中发现了正常组织中没有的MoV和VM(p<0.001),其中MoV和VM在AT和K中分别最多(p<0.001),位于外周生长区。血管分布与肿瘤进展相关(r=-0.541 MVD;r=+0.760 MoVD,r=+0.733 VMD),AT 和 K 中 MVD 的减少与 MoVD 和 VMD 的增加成反比(r=-0.503 和 r=-0.456)。结论 识别甲状旁腺肿瘤中的 "替代 "血管至关重要,因为它:(1) 解释了非血管生成性肿瘤的矛盾之处,即由新的血腥非内皮血管网络组成;(2) 帮助病理学家揭示令人担忧的病变。此外,在人类肿瘤中发现替代性血管系统可以解释抗血管生成疗法的有限成功,并鼓励新的肿瘤学研究。与该研究相关的所有数据都包含在文章中或作为补充信息上传。
{"title":"Vascular mimicry and mosaic vessels in parathyroid tumours: a new diagnostic approach?","authors":"Monica Falleni, Matteo Dal Lago, Delfina Tosi, Giorgio Ghilardi, Loredana De Pasquale, Alberto M Saibene, Giovanni Felisati, Mario Cozzolino, Umberto Gianelli","doi":"10.1136/jcp-2024-209703","DOIUrl":"https://doi.org/10.1136/jcp-2024-209703","url":null,"abstract":"Aims Evaluation of ‘alternative’ vascularisation in human cancer is considered an important prognostic parameter; the 2022 WHO classification of parathyroid tumours despite progresses in clinical triaging of patients strongly emphasises new histopathological parameters to properly stratify these lesions. ‘Alternative’ and ‘classic’ vessels were here investigated for the first time in parathyroid tumours for their possible histopathological and clinical relevance during progression. Methods Using a double CD31/PAS staining, microvessel density (MVD, ‘classic’ CD31+ vessels), mosaic vessel density (MoVD, ‘alternative’ CD31+/−vessels) and vessel mimicry density (VMD, ‘alternative’ CD31−/PAS+ vessels) were evaluated in 4 normal parathyroid glands (N), 50 Adenomas (A), 35 Atypical Tumours (AT) and 10 Carcinomas (K). Results Compared with N, MVD significantly increased in A (p=0.012) and decreased in K (p=0.013) with vessel counts lower than in AT and A (p<0.001). MoVs and VMs, absent in normal tissue, were documented in non-benign parathyroid lesions (AT, K) (p<0.001), with MoVs and VMs most represented in AT and K, respectively (p<0.001), in peripheral growing areas. Vessel distribution was correlated to neoplastic progression (r=−0.541 MVD; r=+0.760 MoVD, r=+0.733 VMD), with MVD decrease in AT and K inversely related to MoVD and VMD increase (r=−0.503 and r=−0.456). Conclusions ‘Alternative’ vessel identification in parathyroid tumours is crucial because it: (1) explains the paradox of non-angiogenic tumours, consisting in a new bloody non-endothelial vessel network and (2) helps pathologists to unmask worrisome lesions. Furthermore, detection of alternative vascular systems in human tumours might explain the limited success of antiangiogenic therapies and encourage new oncological studies. All data relevant to the study are included in the article or uploaded as supplementary information.","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune checkpoint inhibitor-induced gastrointestinal injury: prevalence of cytomegalovirus, adenovirus and Epstein-Barr virus 免疫检查点抑制剂诱发的胃肠道损伤:巨细胞病毒、腺病毒和爱泼斯坦-巴氏病毒的流行情况
IF 3.4 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-16 DOI: 10.1136/jcp-2024-209621
Yevgen Chornenkyy, Carissa LaBoy, Sergei Xavier De Hoyos, Jingjing Hu, Maryam Pezhouh
Aims Widespread use of immune checkpoint inhibitors (ICIs) for treatment of advanced malignancies led to an increase in number of immune-related adverse events such as ICI gastrointestinal (GI) injury (ICIGI). The resulting immune dysregulation of the GI mucosa is believed to predispose patients to viral infections. We characterised the histopathological features of ICIGI and the frequency of viral infections such as cytomegalovirus (CMV), adenovirus, and Epstein-Barr virus (EBV). Methods Single-centre retrospective study (2011–2020). Results 81 GI biopsies from 31 patients with ICIGI (65% male (20/31), 35% female (11/31)) with advanced malignancies were reviewed. Most patients received ipilimumab and nivolumab (14/31, 45%), followed by pembrolizumab (9/31, 29%), ipilimumab (4/31, 13%), nivolumab (2/31, 6%) and combination of all three medications (2/31, 6%). Average regimen prior to incidence of diarrhea was three cycles. Evidence of colitis or erythema by endoscopy was present in 77% of cases, while 23% showed normal endoscopy. Histologically, the predominant ICIGI findings were active inflammation (84%), including cryptitis (77%), crypt abscesses (65%), lymphocytic colitis-like (LCL) pattern (61%), increase in epithelial apoptosis (74%) and/or surface injury (81%). Only one case showed diffuse CMV positivity (3%) with characteristic CMV viral cytopathic effects present on H&E stain and four cases were positive for rare EBV (13%). Adenovirus infection was not identified. Conclusion While our cohort is small, ICIGI generally demonstrates active inflammation including cryptitis and crypt abscesses in the colon, LCL pattern, and an increase in epithelial apoptosis. Upfront immunohistochemistry for viral infection without high-degree of clinical and histologic suspicion is not recommended. All data relevant to the study are included in the article or uploaded as supplementary information.
目的 广泛使用免疫检查点抑制剂(ICIs)治疗晚期恶性肿瘤导致免疫相关不良事件增多,如 ICI 胃肠道损伤(ICIGI)。据信,由此导致的消化道粘膜免疫失调易使患者受到病毒感染。我们研究了 ICIGI 的组织病理学特征以及巨细胞病毒 (CMV)、腺病毒和 Epstein-Barr 病毒 (EBV) 等病毒感染的频率。方法 单中心回顾性研究(2011-2020 年)。结果 对31例晚期恶性肿瘤ICIGI患者(65%为男性(20/31),35%为女性(11/31))的81例消化道活检进行了回顾性研究。大多数患者接受了伊匹单抗和尼伐单抗治疗(14/31,45%),其次是pembrolizumab(9/31,29%)、伊匹单抗(4/31,13%)、尼伐单抗(2/31,6%)以及三种药物的联合治疗(2/31,6%)。腹泻发生前的平均疗程为三个周期。77%的病例通过内镜检查发现结肠炎或红斑,23%的病例内镜检查正常。从组织学角度看,ICIGI 的主要发现是活动性炎症(84%),包括隐窝炎(77%)、隐窝脓肿(65%)、淋巴细胞性结肠炎样(LCL)模式(61%)、上皮细胞凋亡增加(74%)和/或表面损伤(81%)。只有一个病例呈弥漫性 CMV 阳性(3%),H&E 染色显示出特征性的 CMV 病毒细胞病理效应,四个病例呈罕见的 EBV 阳性(13%)。未发现腺病毒感染。结论 虽然我们的队列规模较小,但 ICIGI 通常表现为活动性炎症,包括结肠隐窝炎和隐窝脓肿、LCL 模式和上皮细胞凋亡增加。在没有临床和组织学高度怀疑的情况下,不建议对病毒感染进行前期免疫组化。与该研究相关的所有数据均包含在文章中或作为补充信息上传。
{"title":"Immune checkpoint inhibitor-induced gastrointestinal injury: prevalence of cytomegalovirus, adenovirus and Epstein-Barr virus","authors":"Yevgen Chornenkyy, Carissa LaBoy, Sergei Xavier De Hoyos, Jingjing Hu, Maryam Pezhouh","doi":"10.1136/jcp-2024-209621","DOIUrl":"https://doi.org/10.1136/jcp-2024-209621","url":null,"abstract":"Aims Widespread use of immune checkpoint inhibitors (ICIs) for treatment of advanced malignancies led to an increase in number of immune-related adverse events such as ICI gastrointestinal (GI) injury (ICIGI). The resulting immune dysregulation of the GI mucosa is believed to predispose patients to viral infections. We characterised the histopathological features of ICIGI and the frequency of viral infections such as cytomegalovirus (CMV), adenovirus, and Epstein-Barr virus (EBV). Methods Single-centre retrospective study (2011–2020). Results 81 GI biopsies from 31 patients with ICIGI (65% male (20/31), 35% female (11/31)) with advanced malignancies were reviewed. Most patients received ipilimumab and nivolumab (14/31, 45%), followed by pembrolizumab (9/31, 29%), ipilimumab (4/31, 13%), nivolumab (2/31, 6%) and combination of all three medications (2/31, 6%). Average regimen prior to incidence of diarrhea was three cycles. Evidence of colitis or erythema by endoscopy was present in 77% of cases, while 23% showed normal endoscopy. Histologically, the predominant ICIGI findings were active inflammation (84%), including cryptitis (77%), crypt abscesses (65%), lymphocytic colitis-like (LCL) pattern (61%), increase in epithelial apoptosis (74%) and/or surface injury (81%). Only one case showed diffuse CMV positivity (3%) with characteristic CMV viral cytopathic effects present on H&E stain and four cases were positive for rare EBV (13%). Adenovirus infection was not identified. Conclusion While our cohort is small, ICIGI generally demonstrates active inflammation including cryptitis and crypt abscesses in the colon, LCL pattern, and an increase in epithelial apoptosis. Upfront immunohistochemistry for viral infection without high-degree of clinical and histologic suspicion is not recommended. All data relevant to the study are included in the article or uploaded as supplementary information.","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":3.4,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142268738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study. PD-L1在中国复发或转移性头颈部鳞状细胞癌中的表达(EXCEED研究):一项多中心回顾性研究。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-10 DOI: 10.1136/jcp-2023-209059
Haizhen Lu, Dong Kuang, Ping Zhou, Jing Zeng, Qingxin Xia, Jian Wang, Pei Duan, Lili Jiang, Shengbing Zang, Yiping Jin, Xiangnan Jiang, Jielin Li, Wenmin Tang, Jiansong Zhou, Jihua Chen, Jianming Ying

Aims: Programmed death-ligand 1 (PD-L1) is known to be highly expressed in various malignancies, including head and neck squamous cell carcinoma (HNSCC). We aimed to determine the prevalence of PD-L1 expression in recurrent or metastatic HNSCC (R/M HNSCC) among Chinese patients.

Methods: This multicentre, retrospective analysis of data from six centres in China included patients with R/M HNSCC treated from 9 August 2021 to 28 February 2022. PD-L1 expression in tumour tissue was assessed and represented using a combined positive score (CPS). The χ2 and Cochran-Mantel-Haenszel χ2 tests were used to compare the prevalence of different PD-L1 expression statuses according to related co-variables.

Results: For all 402 examined patients with R/M HNSCC, 168 cases (41.8%) had PD-L1 expression with a CPS ≥20, and 337 cases (83.8%) had PD-L1 expression with a CPS ≥1. Between the PD-L1 CPS ≥20 group and PD-L1 CPS <20 group, statistically significant differences were observed for variables of sex (p<0.001), smoking habit (p=0.0138 for non-smokers vs current smokers) and primary tumour site (p<0.001 for hypopharynx vs oral cavity and p=0.0304 for larynx vs oral cavity, respectively).

Conclusion: PD-L1 with CPS ≥20 was expressed in about 41.8% of cases with R/M HNSCC among Chinese patients, and PD-L1 expression was significantly associated with sex, smoking history and primary tumour site. Our findings regarding the variables related to PD-L1 expression level provide insight for clinical practice and a solid basis for future research on immunotherapy in HNSCC.

Trial registration number: ISRCTN10570964.

目的:程序性死亡配体1 (PD-L1)在多种恶性肿瘤中高表达,包括头颈部鳞状细胞癌(HNSCC)。我们的目的是确定PD-L1表达在中国复发或转移性HNSCC (R/M HNSCC)患者中的患病率。方法:这项多中心回顾性分析来自中国六个中心的数据,包括2021年8月9日至2022年2月28日接受治疗的R/M HNSCC患者。PD-L1在肿瘤组织中的表达被评估,并使用联合阳性评分(CPS)表示。采用χ2检验和Cochran-Mantel-Haenszel χ2检验,根据相关协变量比较不同PD-L1表达状态的患病率。结果:在所有402例R/M型HNSCC患者中,168例(41.8%)PD-L1表达,CPS≥20,337例(83.8%)PD-L1表达,CPS≥1。结论:PD-L1 CPS≥20组与PD-L1 CPS之间的比较:中国R/M型HNSCC患者中约41.8%的患者表达PD-L1 CPS≥20,且PD-L1表达与性别、吸烟史和原发肿瘤部位显著相关。我们关于PD-L1表达水平相关变量的研究结果为临床实践提供了见解,并为未来HNSCC免疫治疗的研究奠定了坚实的基础。试验注册号:ISRCTN10570964。
{"title":"PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study.","authors":"Haizhen Lu, Dong Kuang, Ping Zhou, Jing Zeng, Qingxin Xia, Jian Wang, Pei Duan, Lili Jiang, Shengbing Zang, Yiping Jin, Xiangnan Jiang, Jielin Li, Wenmin Tang, Jiansong Zhou, Jihua Chen, Jianming Ying","doi":"10.1136/jcp-2023-209059","DOIUrl":"10.1136/jcp-2023-209059","url":null,"abstract":"<p><strong>Aims: </strong>Programmed death-ligand 1 (PD-L1) is known to be highly expressed in various malignancies, including head and neck squamous cell carcinoma (HNSCC). We aimed to determine the prevalence of PD-L1 expression in recurrent or metastatic HNSCC (R/M HNSCC) among Chinese patients.</p><p><strong>Methods: </strong>This multicentre, retrospective analysis of data from six centres in China included patients with R/M HNSCC treated from 9 August 2021 to 28 February 2022. PD-L1 expression in tumour tissue was assessed and represented using a combined positive score (CPS). The χ<sup>2</sup> and Cochran-Mantel-Haenszel χ<sup>2</sup> tests were used to compare the prevalence of different PD-L1 expression statuses according to related co-variables.</p><p><strong>Results: </strong>For all 402 examined patients with R/M HNSCC, 168 cases (41.8%) had PD-L1 expression with a CPS ≥20, and 337 cases (83.8%) had PD-L1 expression with a CPS ≥1. Between the PD-L1 CPS ≥20 group and PD-L1 CPS <20 group, statistically significant differences were observed for variables of sex (p<0.001), smoking habit (p=0.0138 for non-smokers vs current smokers) and primary tumour site (p<0.001 for hypopharynx vs oral cavity and p=0.0304 for larynx vs oral cavity, respectively).</p><p><strong>Conclusion: </strong>PD-L1 with CPS ≥20 was expressed in about 41.8% of cases with R/M HNSCC among Chinese patients, and PD-L1 expression was significantly associated with sex, smoking history and primary tumour site. Our findings regarding the variables related to PD-L1 expression level provide insight for clinical practice and a solid basis for future research on immunotherapy in HNSCC.</p><p><strong>Trial registration number: </strong>ISRCTN10570964.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134649001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates in non-neoplastic orthopaedic pathology: what you don't know can hurt you! 非肿瘤性骨科病理学的最新进展:不知者无畏!
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-09-05 DOI: 10.1136/jcp-2024-209700
Nooshin K Dashti, John D Reith, Scott E Kilpatrick

Even though the average surgical pathologist reviews far more non-neoplastic orthopaedic pathology on a daily basis, most current research focuses on rare tumours and their even less frequent molecular events. Our experiences among consults and focused conferences strongly suggest that there remains a practice gap regarding knowledge and diagnosing specific non-neoplastic orthopaedic conditions. One of the most frequent intraoperative consultations performed in the USA, among both academic and private institutions, relates to revision arthroplasty and the determination of infection in periprosthetic joints. Pathologists play a critical role in this algorithm, helping determine intraoperatively whether patients require antibiotic spacers prior to reimplantation. Many pathology departments have abandoned the examination of arthroplasty specimens because they (and their surgeons) mistakenly believe there is little clinically relevant information to be gained by thorough pathological examination. However, recent literature has challenged this concept, emphasising the importance of distinguishing avascular necrosis (from osteoarthritis/degenerative joint disease with secondary osteonecrosis), subchondral insufficiency fracture, septic arthritis (from so-called 'sterile' osteomyelitis/pseudoabscesses), underlying crystalline diseases and incidental/occult neoplasia. Histological evaluation of historically insignificant orthopaedic specimens, such as tenosynovium from carpal tunnel syndrome/trigger finger, is now seen as valuable in early diagnosis of cardiac amyloidosis. Not infrequently, orthopaedic conditions like haemosiderotic synovitis, osteocartilaginous loose bodies or rheumatoid nodules, may histologically mimic bona fide neoplasms, notably diffuse tenosynovial giant cell tumour, synovial chondromatosis and epithelioid sarcoma, respectively. Here is a review of the more common non-neoplastic orthopaedic conditions, those likely to be examined by the practising surgical pathologist, with updates and guidelines for establishing clinically relevant diagnoses.

尽管普通的外科病理学家每天都要审查更多的非肿瘤性骨科病理,但目前的大多数研究都集中在罕见肿瘤及其更不常见的分子事件上。我们在会诊和集中会议中的经验强烈表明,在特定非肿瘤性骨科疾病的知识和诊断方面仍存在实践差距。在美国的学术机构和私人机构中,最常见的术中会诊之一与翻修关节成形术和假体周围关节感染的判断有关。病理学家在这种算法中起着至关重要的作用,他们在术中帮助确定患者是否需要在再植前使用抗生素垫片。许多病理部门已经放弃了对关节成形术标本的检查,因为他们(及其外科医生)错误地认为通过彻底的病理检查几乎无法获得与临床相关的信息。然而,最近的文献对这一观点提出了质疑,强调了区分血管性坏死(与继发性骨坏死的骨关节炎/退行性关节病)、软骨下不全骨折、化脓性关节炎(与所谓的 "无菌性 "骨髓炎/假性脓肿)、潜在的结晶性疾病以及偶发/偶见肿瘤的重要性。对历史上无关紧要的骨科标本(如腕管综合征/扳机指的腱鞘)进行组织学评估,现在被认为对早期诊断心脏淀粉样变性很有价值。骨科疾病,如血滑膜炎、骨软骨松散体或类风湿结节,在组织学上可能与真正的肿瘤相似,尤其是弥漫性腱鞘巨细胞瘤、滑膜软骨瘤病和上皮样肉瘤。以下回顾了较常见的非肿瘤性骨科疾病,即执业外科病理学家可能会检查的疾病,并提供了确定临床相关诊断的最新信息和指南。
{"title":"Updates in non-neoplastic orthopaedic pathology: what you don't know can hurt you!","authors":"Nooshin K Dashti, John D Reith, Scott E Kilpatrick","doi":"10.1136/jcp-2024-209700","DOIUrl":"https://doi.org/10.1136/jcp-2024-209700","url":null,"abstract":"<p><p>Even though the average surgical pathologist reviews far more non-neoplastic orthopaedic pathology on a daily basis, most current research focuses on rare tumours and their even less frequent molecular events. Our experiences among consults and focused conferences strongly suggest that there remains a practice gap regarding knowledge and diagnosing specific non-neoplastic orthopaedic conditions. One of the most frequent intraoperative consultations performed in the USA, among both academic and private institutions, relates to revision arthroplasty and the determination of infection in periprosthetic joints. Pathologists play a critical role in this algorithm, helping determine intraoperatively whether patients require antibiotic spacers prior to reimplantation. Many pathology departments have abandoned the examination of arthroplasty specimens because they (and their surgeons) mistakenly believe there is little clinically relevant information to be gained by thorough pathological examination. However, recent literature has challenged this concept, emphasising the importance of distinguishing avascular necrosis (from osteoarthritis/degenerative joint disease with secondary osteonecrosis), subchondral insufficiency fracture, septic arthritis (from so-called 'sterile' osteomyelitis/pseudoabscesses), underlying crystalline diseases and incidental/occult neoplasia. Histological evaluation of historically insignificant orthopaedic specimens, such as tenosynovium from carpal tunnel syndrome/trigger finger, is now seen as valuable in early diagnosis of cardiac amyloidosis. Not infrequently, orthopaedic conditions like haemosiderotic synovitis, osteocartilaginous loose bodies or rheumatoid nodules, may histologically mimic bona fide neoplasms, notably diffuse tenosynovial giant cell tumour, synovial chondromatosis and epithelioid sarcoma, respectively. Here is a review of the more common non-neoplastic orthopaedic conditions, those likely to be examined by the practising surgical pathologist, with updates and guidelines for establishing clinically relevant diagnoses.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using decision support platforms to enhance cancer diagnostics: the importance of vigilance and wise decision-making. 利用决策支持平台加强癌症诊断:警惕和明智决策的重要性。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-08-29 DOI: 10.1136/jcp-2024-209706
Hyunji Kim, Kyoung Un Park
{"title":"Using decision support platforms to enhance cancer diagnostics: the importance of vigilance and wise decision-making.","authors":"Hyunji Kim, Kyoung Un Park","doi":"10.1136/jcp-2024-209706","DOIUrl":"https://doi.org/10.1136/jcp-2024-209706","url":null,"abstract":"","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142107909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EWSR1: the promiscuous king of mesenchymal neoplasia. EWSR1:间充质肿瘤的杂交之王。
IF 2.5 4区 医学 Q2 PATHOLOGY Pub Date : 2024-08-28 DOI: 10.1136/jcp-2023-208867
Emily Anne Towery, David James Papke

EWSR1 is the most commonly rearranged gene in mesenchymal neoplasia, and its myriad chimeric oncoproteins drive widely disparate neoplasms. Here, we survey selected EWSR1 rearrangements, including well-described EWSR1 fusions with CREB family members, ATF1 and CREB1, as well as fusions in emerging entities such as mesenchymal neoplasms with EWSR1::PATZ1 and EWSR1::NFATC2 fusions. We also discuss recent data demonstrating the imperfect specificity of EWSR1::WT1 and, possibly, EWSR1::FLI1 fusions.

EWSR1 是间充质肿瘤中最常见的重排基因,其无数的嵌合癌蛋白驱动着千差万别的肿瘤。在此,我们将对选定的 EWSR1 重排情况进行调查,包括已充分描述的 EWSR1 与 CREB 家族成员 ATF1 和 CREB1 融合的情况,以及新出现的融合情况,如间质肿瘤中的 EWSR1::PATZ1 和 EWSR1::NFATC2 融合。我们还讨论了证明 EWSR1::WT1 以及可能的 EWSR1::FLI1 融合的不完全特异性的最新数据。
{"title":"<i>EWSR1</i>: the promiscuous king of mesenchymal neoplasia.","authors":"Emily Anne Towery, David James Papke","doi":"10.1136/jcp-2023-208867","DOIUrl":"https://doi.org/10.1136/jcp-2023-208867","url":null,"abstract":"<p><p><i>EWSR1</i> is the most commonly rearranged gene in mesenchymal neoplasia, and its myriad chimeric oncoproteins drive widely disparate neoplasms. Here, we survey selected <i>EWSR1</i> rearrangements, including well-described <i>EWSR1</i> fusions with CREB family members, <i>ATF1</i> and <i>CREB1</i>, as well as fusions in emerging entities such as mesenchymal neoplasms with <i>EWSR1::PATZ1</i> and <i>EWSR1::NFATC2</i> fusions. We also discuss recent data demonstrating the imperfect specificity of <i>EWSR1::WT1</i> and, possibly, <i>EWSR1::FLI1</i> fusions.</p>","PeriodicalId":15391,"journal":{"name":"Journal of Clinical Pathology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142107907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1